I-Bridge Capital (I-Bridge) is a venture capital firm that focuses on incubating and/or investing in companies in China’s healthcare sector. The firm has established a joint venture with Israeli drug company, BioLineRx, to incubate innovative healthcare start-ups. The joint venture, named iPharma, seeks to develop innovative clinical and pre-clinical therapeutic projects originating primarily in Israel to serve the Chinese and global healthcare markets.
Venture Capital
1 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.